Bio-Rad Releases First FDA-Cleared Liquid Biopsy Test for Chronic Myeloid Leukemia
Using the kit, clinicians can accurately and reproducibly monitor residual disease in patients with chronic myeloid leukemia, even at low levels.
Read More
Search Results for: Chronic Myeloid Leukemia
Determining Molecular Response in Chronic Myeloid Leukemia
Droplet digital PCR can provide a more accurate assessment of low levels of BCR-ABL mRNA than quantitative real-time PCR.
Read More
Bio-Rad Launches Digital PCR Test for Monitoring Chronic Myeloid Leukemia Response to Therapy
Bio-Rad Laboratories has introduced the QXDx BCR-ABL %IS kit, a CE-marked digital polymerase chain reaction test that can monitor the molecular response to therapy of patients with chronic myeloid leukemia.
Read MoreFDA Grants Clearance for Chronic Myeloid Leukemia Test
Agency allows marketing of the QuantideX qPCR BCR-ABL IS kit, the first nucleic acid-based quantitation test for use during treatment of rare leukemia.
Read More
New Assay Could Revolutionize Acute Myeloid Leukemia Detection
A novel assay that identifies a unique molecular marker in acute myeloid leukemia patients may revolutionize how the disease is detected.
Read More